Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Loop-Recorder (SpiderFLASH)
NCT ID: NCT02253134
Last Updated: 2014-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
395 participants
OBSERVATIONAL
2010-08-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CANadian Clinical Evaluation of SpiderFlash Arrhythmia DETECTion in SpiderFlash™ Device
NCT01218763
Mobile Electrocardiogram Monitoring for Detecting Arrhythmias in Children
NCT05140343
Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy
NCT01265303
Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions.
NCT01265290
Bradycardia Risk Stratification With Loop Recorder After Syncope
NCT04200014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Events likely of arrhythmic origin
* No conclusive diagnosis established yet
* High probability of episodes recurrence (presence of at least one previous event in the last 12 months)
* Patient has signed the consent to participate to the study and/or to data treatment
Exclusion Criteria
* Expected low compliance with the recording technique.
* Logistical impossibility to deliver the ELR within 30 days after the index event (or after discharge from ER and/or hospitalization and/or clinic visit)
* Already included in other competitor clinical study
* Under guardianship
* Age less than 18
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LivaNova
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emanuela T Locati
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedaliera Niguarda Ca' Granda - Milano
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Gasthuisberg Leuven
Leuven, , Belgium
Az. Sanit. Locale N. 4 Chiavarese
Lavagna, , Italy
Ospedale Niguarda Ca Granda
Milan, , Italy
Hospital de Santa Marta
Lisbon, , Portugal
Institut Universitari Dexeus
Barcelona, , Spain
Hospital Vall d'Hebron
Barcelona, , Spain
Hospital Universitari de Bellvitge
Barcelona, , Spain
Hospital de Basurto
Bilbao, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Universitätsklinik für Kardiologie Inselspital
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYNARR-FLASH STUDY - ITHO04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.